XPENG INC - ADR (XPEV) Stock Fundamental Analysis

NYSE:XPEV • US98422D1054

18.18 USD
-0.55 (-2.94%)
At close: Feb 25, 2026
18.19 USD
+0.01 (+0.06%)
After Hours: 2/25/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, XPEV scores 4 out of 10 in our fundamental rating. XPEV was compared to 35 industry peers in the Automobiles industry. XPEV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XPEV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • XPEV had negative earnings in the past year.
  • XPEV had a positive operating cash flow in the past year.
  • In the past 5 years XPEV always reported negative net income.
  • In the past 5 years XPEV reported 4 times negative operating cash flow.
XPEV Yearly Net Income VS EBIT VS OCF VS FCFXPEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B -8B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.63%, XPEV is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
  • The Return On Equity of XPEV (-14.11%) is better than 65.71% of its industry peers.
Industry RankSector Rank
ROA -4.63%
ROE -14.11%
ROIC N/A
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
XPEV Yearly ROA, ROE, ROICXPEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • With a decent Gross Margin value of 16.36%, XPEV is doing good in the industry, outperforming 74.29% of the companies in the same industry.
  • XPEV's Gross Margin has improved in the last couple of years.
  • XPEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.06%
GM growth 5YN/A
XPEV Yearly Profit, Operating, Gross MarginsXPEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

4

2. Health

2.1 Basic Checks

  • XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XPEV has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for XPEV has been increased compared to 5 years ago.
  • XPEV has a worse debt/assets ratio than last year.
XPEV Yearly Shares OutstandingXPEV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
XPEV Yearly Total Debt VS Total AssetsXPEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • Based on the Altman-Z score of 1.11, we must say that XPEV is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.11, XPEV is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
  • The Debt to FCF ratio of XPEV is 2.65, which is a good value as it means it would take XPEV, 2.65 years of fcf income to pay off all of its debts.
  • XPEV has a better Debt to FCF ratio (2.65) than 88.57% of its industry peers.
  • XPEV has a Debt/Equity ratio of 0.78. This is a neutral value indicating XPEV is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.78, XPEV is in line with its industry, outperforming 45.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 2.65
Altman-Z 1.11
ROIC/WACCN/A
WACC8.07%
XPEV Yearly LT Debt VS Equity VS FCFXPEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that XPEV should not have too much problems paying its short term obligations.
  • XPEV's Current ratio of 1.14 is in line compared to the rest of the industry. XPEV outperforms 42.86% of its industry peers.
  • A Quick Ratio of 1.00 indicates that XPEV should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.00, XPEV perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1
XPEV Yearly Current Assets VS Current LiabilitesXPEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

7

3. Growth

3.1 Past

  • XPEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.77%, which is quite impressive.
  • The Revenue has grown by 86.64% in the past year. This is a very strong growth!
  • Measured over the past years, XPEV shows a very strong growth in Revenue. The Revenue has been growing by 77.47% on average per year.
EPS 1Y (TTM)51.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.95%
Revenue 1Y (TTM)86.64%
Revenue growth 3Y24.87%
Revenue growth 5Y77.47%
Sales Q2Q%101.76%

3.2 Future

  • Based on estimates for the next years, XPEV will show a very strong growth in Earnings Per Share. The EPS will grow by 23.29% on average per year.
  • XPEV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.52% yearly.
EPS Next Y74.6%
EPS Next 2Y49.95%
EPS Next 3Y38.07%
EPS Next 5Y23.29%
Revenue Next Year91%
Revenue Next 2Y62.41%
Revenue Next 3Y46.35%
Revenue Next 5Y30.52%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XPEV Yearly Revenue VS EstimatesXPEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50B 100B 150B 200B
XPEV Yearly EPS VS EstimatesXPEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

4

4. Valuation

4.1 Price/Earnings Ratio

  • XPEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 82.37, which means the current valuation is very expensive for XPEV.
  • XPEV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. XPEV is cheaper than 68.57% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.03. XPEV is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 82.37
XPEV Price Earnings VS Forward Price EarningsXPEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

  • 88.57% of the companies in the same industry are more expensive than XPEV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.67
EV/EBITDA N/A
XPEV Per share dataXPEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • XPEV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • XPEV's earnings are expected to grow with 38.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.95%
EPS Next 3Y38.07%

0

5. Dividend

5.1 Amount

  • No dividends for XPEV!.
Industry RankSector Rank
Dividend Yield 0%

XPENG INC - ADR

NYSE:XPEV (2/25/2026, 8:04:00 PM)

After market: 18.19 +0.01 (+0.06%)

18.18

-0.55 (-2.94%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-17
Earnings (Next)03-18
Inst Owners12.75%
Inst Owner Change-8.71%
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap17.34B
Revenue(TTM)70.57B
Net Income(TTM)-4.28B
Analysts80.59
Price Target27.75 (52.64%)
Short Float %9.89%
Short Ratio4.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.32%
Min EPS beat(2)34.81%
Max EPS beat(2)47.83%
EPS beat(4)2
Avg EPS beat(4)18.11%
Min EPS beat(4)-8.69%
Max EPS beat(4)47.83%
EPS beat(8)4
Avg EPS beat(8)16.95%
EPS beat(12)4
Avg EPS beat(12)3.67%
EPS beat(16)6
Avg EPS beat(16)-1.04%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.52%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)2.52%
Revenue beat(8)2
Avg Revenue beat(8)-2.74%
Revenue beat(12)2
Avg Revenue beat(12)-5.64%
Revenue beat(16)5
Avg Revenue beat(16)-2.91%
PT rev (1m)-0.99%
PT rev (3m)1.09%
EPS NQ rev (1m)-6.89%
EPS NQ rev (3m)-6.89%
EPS NY rev (1m)2.13%
EPS NY rev (3m)-10.11%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 82.37
P/S 1.98
P/FCF 11.67
P/OCF 9.17
P/B 3.93
P/tB 4.6
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)0.22
Fwd EY1.21%
FCF(TTM)1.56
FCFY8.57%
OCF(TTM)1.98
OCFY10.91%
SpS9.18
BVpS4.62
TBVpS3.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -14.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.36%
FCFM 16.96%
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 2.65
Debt/EBITDA N/A
Cap/Depr 129.52%
Cap/Sales 4.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1
Altman-Z 1.11
F-Score6
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)238.42%
Cap/Depr(5y)371.52%
Cap/Sales(3y)10.3%
Cap/Sales(5y)14.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.95%
EPS Next Y74.6%
EPS Next 2Y49.95%
EPS Next 3Y38.07%
EPS Next 5Y23.29%
Revenue 1Y (TTM)86.64%
Revenue growth 3Y24.87%
Revenue growth 5Y77.47%
Sales Q2Q%101.76%
Revenue Next Year91%
Revenue Next 2Y62.41%
Revenue Next 3Y46.35%
Revenue Next 5Y30.52%
EBIT growth 1Y26.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.98%
EBIT Next 3Y41.34%
EBIT Next 5Y30.46%
FCF growth 1Y164.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y206.97%
OCF growth 3YN/A
OCF growth 5YN/A

XPENG INC - ADR / XPEV FAQ

Can you provide the ChartMill fundamental rating for XPENG INC - ADR?

ChartMill assigns a fundamental rating of 4 / 10 to XPEV.


What is the valuation status for XPEV stock?

ChartMill assigns a valuation rating of 4 / 10 to XPENG INC - ADR (XPEV). This can be considered as Fairly Valued.


How profitable is XPENG INC - ADR (XPEV) stock?

XPENG INC - ADR (XPEV) has a profitability rating of 2 / 10.